uCD7 CAR-T

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for uCD7 CAR-T, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies [Phase 1]